Invivyd, Inc. - IVVD
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Aug 14, 2026 | SCHEDULE 13G/A | Perceptive Advisors LLC | 6.3% | 18,490,636 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Joseph Edelman | 6.3% | 18,490,636 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Perceptive Life Sciences Master Fund, Ltd. | 6.3% | 18,490,636 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | BIOTECHNOLOGY VALUE FUND L P | 5.4% | 16,031,969 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | BVF I GP LLC | 5.4% | 16,031,969 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | BIOTECHNOLOGY VALUE FUND II LP | 3.8% | 11,183,991 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | BVF II GP LLC | 3.8% | 11,183,991 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Biotechnology Value Trading Fund OS LP | 0.6% | 1,887,918 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | BVF Partners OS Ltd. | 0.6% | 1,887,918 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | BVF GP HOLDINGS LLC | 9.2% | 27,215,960 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | BVF PARTNERS L P/IL | 9.99% | 29,571,826 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | BVF INC/IL | 9.99% | 29,571,826 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | LAMPERT MARK N | 9.99% | 29,571,826 | View |
| Jul 28, 2026 | SCHEDULE 13G | BlackRock, Inc. | 5.5% | 16,124,696 | View |
| May 15, 2026 | SCHEDULE 13G/A | RA Capital Management, L.P. | 7.0% | 21,342,442 | View |
| May 15, 2026 | SCHEDULE 13G/A | Peter Kolchinsky | 7.0% | 21,342,442 | View |
| May 15, 2026 | SCHEDULE 13G/A | Rajeev Shah | 7.0% | 21,342,442 | View |
| May 15, 2026 | SCHEDULE 13G/A | RA Capital Healthcare Fund, L.P. | 7.0% | 21,342,442 | View |
| May 15, 2026 | SCHEDULE 13G/A | Point72 Asset Management, L.P. | 0.0% | 43,931 | View |
| May 15, 2026 | SCHEDULE 13G/A | Point72 Capital Advisors, Inc. | 0.0% | 43,931 | View |
| May 15, 2026 | SCHEDULE 13G/A | Steven A. Cohen | 0.0% | 43,931 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.